General
Preferred name
PIR 3.5
Synonyms
6,6′-Dithiodi(2-naphthol) ()
2,2′-Dihydroxy-6,6′-dinaphthyl disulfide ()
DDD ()
Bis(6-hydroxy-2-naphthyl)disulfide ()
PIR-3.5 ()
P&D ID
PD070094
CAS
6088-51-3
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
86
DESCRIPTION
PIR 3.5 (6,6??-Dithiodi(2-naphthol)) is a negative control of IPA 3 which is a Pak1 inhibitor.
DESCRIPTION
PIR 3.5 is a negative control of IPA 3, an allosteric inhibitor of group I PAK activation.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
PIR 3.5 (6,6′-Dithiodi(2-naphthol)) is a negative control of IPA 3 which is a Pak1 inhibitor.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
3
BOC Sciences Bioactive Compounds
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
18
Molecular Weight
350.04
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
4
Aromatic Ring Count
4
cLogP
6.2
TPSA
40.46
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.43
Structural alerts
2
aggregator (Aggregator Advisor)
Aggregators
aggregator (ZINC)
Aggregators
Related compounds
Custom attributes
(extracted from source data)
Target
PAK1
PAK
Pathway
Cytoskeletal Signaling
Cell Cycle/DNA Damage
cytoskeleton
Source data
